{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:05Z","timestamp":1791118745727,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1681\/asn.2013030290","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T23:07:06Z","timestamp":1385075226000},"page":"675-680","source":"Crossref","is-referenced-by-count":46,"title":["Allo-Immune Membranous Nephropathy and Recombinant Aryl Sulfatase Replacement Therapy"],"prefix":"10.1681","volume":"25","author":[{"given":"Hanna","family":"Debiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassili","family":"Valayannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure-H\u00e9l\u00e8ne","family":"N\u00f6el","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Callard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Sarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"de Lonlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Niaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20230208","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-8-20230208","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"R3-8-20230208","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1097\/01.ASN.0000141462.00630.76","article-title":"The molecular basis of Goodpasture and Alport syndromes: Beacons for the discovery of the collagen IV family.","volume":"15","author":"Hudson","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R4-8-20230208","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-200202150-00013","article-title":"Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: Role of nephrin.","volume":"73","author":"Patrakka","year":"2002","journal-title":"Transplantation"},{"key":"R5-8-20230208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1529-1049(02)00049-1","article-title":"Immunologic considerations for enzyme replacement therapy in the treatment of lysosomal storage disorders.","volume":"2","author":"Richards","year":"2002","journal-title":"Clin Appl Immunol Rev"},{"key":"R6-8-20230208","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/mgme.1999.2894","article-title":"Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models.","volume":"68","author":"Brooks","year":"1999","journal-title":"Mol Genet Metab"},{"key":"R7-8-20230208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1389201023378175","article-title":"Immune responses to therapeutic proteins in humans\u2014clinical significance, assessment and prediction.","volume":"3","author":"Koren","year":"2002","journal-title":"Curr Pharm Biotechnol"},{"key":"R8-8-20230208","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1542\/peds.2003-0988-L","article-title":"Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.","volume":"114","author":"Hunley","year":"2004","journal-title":"Pediatrics"},{"key":"R9-8-20230208","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1042\/bst0280150","article-title":"The molecular basis of lysosomal storage diseases and their treatment.","volume":"28","author":"Winchester","year":"2000","journal-title":"Biochem Soc Trans"},{"key":"R10-8-20230208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI.","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R11-8-20230208","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.113.5.899","article-title":"Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.","volume":"113","author":"Dixon","year":"1961","journal-title":"J Exp Med"},{"key":"R12-8-20230208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMe0903343","article-title":"Human idiopathic membranous nephropathy\u2014a mystery solved?","volume":"361","author":"Glassock","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-8-20230208","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: Recent advances and future challenges.","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R14-8-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R15-8-20230208","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin.","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-8-20230208","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.","volume":"148","author":"Harmatz","year":"2006","journal-title":"J Pediatr"},{"key":"R17-8-20230208","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10545-011-9410-9","article-title":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).","volume":"36","author":"Hendriksz","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R18-8-20230208","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1681\/ASN.2008121286","article-title":"Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.","volume":"20","author":"Giardino","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R19-8-20230208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(00)00254-5","article-title":"Inhibition of the human intermediate conductance Ca(2+)-activated K(+) channel, hIK1, by volatile anesthetics.","volume":"395","author":"Namba","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R20-8-20230208","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1097\/01.ASN.0000145046.24268.0D","article-title":"Human podocytes possess a stretch-sensitive, Ca2+-activated K+ channel: Potential implications for the control of glomerular filtration.","volume":"15","author":"Morton","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R21-8-20230208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.","volume":"149","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"R22-8-20230208","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V93.6.2081.406k07_2081_2088","article-title":"Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: Induction of humoral tolerance in seroconverted patients after repeat administration.","volume":"93","author":"Rosenberg","year":"1999","journal-title":"Blood"},{"key":"R23-8-20230208","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nbt.1484","article-title":"Neutralizing antibodies to therapeutic enzymes: Considerations for testing, prevention and treatment.","volume":"26","author":"Wang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R24-8-20230208","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3\u03ba targeting the PLA2 receptor.","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:24Z","timestamp":1786130604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201404000-00008"}},"subtitle":["A Need for Tolerance Induction Therapy"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013030290","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}